Titan Biotech Allots 1:4 Bonus Shares; Stock at ₹311.55

Mumbai, October 26: Titan Biotech has allotted 1,03,29,625 fully paid-up bonus equity shares in a 1:4 ratio, giving eligible shareholders one additional share for every four existing shares held. The allotment was approved by the company’s board on October 26, 2026, following shareholder approval at its annual general meeting on September 29.

The bonus shares will be credited to eligible shareholders within the stipulated timelines. The record date for determining eligibility was October 23, 2026.

Titan Biotech Bonus Issue: Share Capital Details

The bonus issue increases Titan Biotech’s paid-up equity share capital from ₹8,26,37,000 to ₹10,32,96,250.

The allotment follows the company’s earlier recommendation and subsequent shareholder approval for the bonus issue.

Stock Market Snapshot

The Titan Biotech share price was trading at ₹311.55 around 10:28 AM on Monday, October 26, 2026. The supplied market chart does not clearly establish the previous closing price or opening price, so the percentage movement cannot be stated reliably here.

A bonus issue increases the number of shares held by eligible investors but does not, by itself, increase the value of their overall investment. The market price may adjust to reflect the higher number of shares.

About Titan Biotech

Titan Biotech is an Indian company operating in the biotechnology sector, supplying products for applications across industries such as pharmaceuticals, food and healthcare.

Conclusion

Titan Biotech has completed the allotment of bonus shares in a 1:4 ratio, increasing its paid-up equity share capital. Eligible shareholders will receive the additional shares in line with the company’s stated timeline.

Source:

• https://www.bseindia.com/stock-share-price/titan-biotech-ltd/titanbio/524717
• https://www.bseindia.com/xml-data/corpfiling/AttachLive/f86496d5-2294-4018-9d69-8a03d1893118.pdf